Results of your search
-
David Kaufman - Director - has a Ph.D. in Molecular Virology & Immunology from Rockefeller University and Medical Doctorate from Weill Cornell Medical College of Cornell University.Abata Therapeutics - Healthcare - United States (USA)
-
David Baltimore - Lead Independent Director - has a PhD in Biology from Rockefeller University and Bachelor of Arts in Chemistry from Swarthmore College.Altos Labs - Biotechnology - United States (USA)
-
Jessica Hopfield - Lead Independent Director - has a PhD in Neuroscience and Biochemistry from Rockefeller University and Master of Business Administration from Harvard Business School.Insulet - Medical Equipment - United States (USA)
-
David Baltimore - Chairman of the Board - has a PhD in Biology from Rockefeller University and Bachelor of Arts in Chemistry from Swarthmore College.Appia Bio - Biotechnology - United States (USA)
-
Mina Pastagia - Chief Medical Officer - has a Master in Translational Medicine from Rockefeller University and Doctor of Medicine from State University of New York Downstate Medical Center College of Medicine.Armata Pharmaceuticals - Biotechnology - United States (USA)
-
Kevin Gorman - Chief Development Officer - has a Post-Doctoral Training from Rockefeller University and Ph.D. degree in Immunology and M.B.A. in Finance from University of California, Los Angeles.Oxitec - Biotechnology - United Kingdom (UK)
-
Jessica Hopfield - Director - has a PhD in Neuroscience and Biochemistry from Rockefeller University and Master of Business Administration from Harvard Business School.Editas Medicine - Biotechnology - United States (USA)
-
Jessica Hopfield - Director - has a PhD in Neuroscience and Biochemistry from Rockefeller University and Master of Business Administration from Harvard Business School.Maravai LifeSciences - Biotechnology - United States (USA)
-
Kevin Gorman - Director - has a Post-Doctoral Training from Rockefeller University and Ph.D. degree in Immunology and M.B.A. in Finance from University of California, Los Angeles.Xencor - Biotechnology - United States (USA)
-
Brian Wong - Director - has a PhD in Immunology from Rockefeller University and Doctor of Medicine from Joan & Sanford I. Weill Medical College of Cornell University.Plexium - Biotechnology - United States (USA)
-
Zhong Zhong - Chief Scientific Officer - has a PhD from Rockefeller University.Ovid Therapeutics - Biotechnology - United States (USA)
-
Larry Altstiel - Chief Medical Officer - has a PhD in Cell Biology, Virology & Physical Chemistry from Rockefeller University and Residency in Neurology from Columbia University Vagelos College of Physicians and Surgeons.ProMIS Neurosciences - Biotechnology - Canada
-
Kevin Gorman - President, Chief Executive Officer and Director - has a Post-Doctoral Training from Rockefeller University and Ph.D. degree in Immunology and M.B.A. in Finance from University of California, Los Angeles.Neurocrine Biosciences - Biotechnology - United States (USA)
-
Brian Wong - Chief Executive Officer and Director - has a PhD in Immunology from Rockefeller University and Doctor of Medicine from Joan & Sanford I. Weill Medical College of Cornell University.Rapt Therapeutics - Biotechnology - United States (USA)
-
David Kaufman - Director - has a Ph.D. in Molecular Virology & Immunology from Rockefeller University and Medical Doctorate from Weill Cornell Medical College of Cornell University.Hookipa Pharma - Biotechnology - Austria
-
David Kaufman - Partner - has a Ph.D. in Molecular Virology & Immunology from Rockefeller University and Medical Doctorate from Weill Cornell Medical College of Cornell University.Third Rock Ventures - Fund - United States (USA)
-
David Baltimore - Director - has a PhD in Biology from Rockefeller University and Bachelor of Arts in Chemistry from Swarthmore College.Regulus Therapeutics - Biotechnology - United States (USA)